Michal Bahar1, Uwe Kordes2, Tanya Tekautz3, Johannes Wolff3. 1. Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, U.S.A. baharm@ccf.org. 2. Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 3. Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, U.S.A.
Abstract
BACKGROUND: Choroid plexus carcinomas (CPCs) are rare pediatric tumors often associated with Li-Fraumeni Syndrome (LFS), a germline mutation in the TP53 tumor-suppressor gene, predisposing to cancer. MATERIALS AND METHODS: We performed a systemic literature review from 1990-2013 to evaluate the hypothesis that radiation therapy should be avoided in patients with CPC and LFS. Overall survival (OS) was compared using Kaplan-Meier curves and log-rank tests. RESULTS: Twenty-eight patients were documented with CPC and LFS. Eleven out of 17 patients received radiation therapy. The survival of patients receiving radiation was inferior to that of those without radiation [median (±95% confidence interval) 2-year OS=0.18 ± 0.12% versus 0.58 ± 0.12%]. The log-rank tests suggested the difference to be marginally significant (p=0.056). CONCLUSION: This finding provides evidence for pursuing treatment approaches that do not include radiation therapy for patients with LFS. Copyright
BACKGROUND:Choroid plexus carcinomas (CPCs) are rare pediatric tumors often associated with Li-Fraumeni Syndrome (LFS), a germline mutation in the TP53tumor-suppressor gene, predisposing to cancer. MATERIALS AND METHODS: We performed a systemic literature review from 1990-2013 to evaluate the hypothesis that radiation therapy should be avoided in patients with CPC and LFS. Overall survival (OS) was compared using Kaplan-Meier curves and log-rank tests. RESULTS: Twenty-eight patients were documented with CPC and LFS. Eleven out of 17 patients received radiation therapy. The survival of patients receiving radiation was inferior to that of those without radiation [median (±95% confidence interval) 2-year OS=0.18 ± 0.12% versus 0.58 ± 0.12%]. The log-rank tests suggested the difference to be marginally significant (p=0.056). CONCLUSION: This finding provides evidence for pursuing treatment approaches that do not include radiation therapy for patients with LFS. Copyright
Authors: Michal Bahar; Hasan Hashem; Tanya Tekautz; Sarah Worley; Anne Tang; Peter de Blank; Johannes Wolff Journal: J Neurooncol Date: 2017-03-13 Impact factor: 4.130
Authors: Anthony P Y Liu; Gang Wu; Brent A Orr; Tong Lin; Jason M Ashford; Johnnie K Bass; Daniel C Bowers; Tim Hassall; Paul G Fisher; Daniel J Indelicato; Paul Klimo; Frederick Boop; Heather Conklin; Arzu Onar-Thomas; Thomas E Merchant; David W Ellison; Amar Gajjar; Giles W Robinson Journal: Neurooncol Adv Date: 2020-12-15
Authors: Maxim Yankelevich; Jonathan L Finlay; Hamza Gorsi; William Kupsky; Daniel R Boue; Carl J Koschmann; Chandan Kumar-Sinha; Rajen Mody Journal: Cold Spring Harb Mol Case Stud Date: 2021-02-19
Authors: Peter G Hendrickson; Yukun Luo; Wendy Kohlmann; Josh Schiffman; Luke Maese; Andrew J Bishop; Shane Lloyd; Kristine E Kokeny; Ying J Hitchcock; Matthew M Poppe; David K Gaffney; Randa Tao Journal: Cancer Med Date: 2020-09-15 Impact factor: 4.452